Predict your next investment

InterVest company logo
Venture Capital
FINANCE | Investment Firms & Funds
intervest.co.kr

See what CB Insights has to offer

Investments

102

Portfolio Exits

9

Funds

2

About InterVest

InterVest is a venture capital firm that specializes in startups and early stage businesses, providing pre-initial public offering financing through mezzanine and bridge transactions. It typically invests in biotechnology, healthcare, semiconductor, display, metal and non-metal, energy, machinery, nanotechnology, telecommunications equipment and services, wireless communication terminal-related hardware, computer, software and applications and digital content sectors in Korea.

InterVest Headquarter Location

#1701 Trade Tower 511, Yeongdong-daero, Gangnam-gu

Seoul, 06164,

South Korea

+82-2-551-7340

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

InterVest Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

InterVest Rank

Research containing InterVest

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned InterVest in 1 CB Insights research brief, most recently on Oct 21, 2019.

Latest InterVest News

Intervest Offices & Warehouses nv announces its first sustainable bond

Jun 14, 2022

Antwerpen, BELGIUM Intervest announces that it has successfully issued its first sustainable bond for a total amount of € 45 million (over 5 years at 3,6%). The issue of this bond almost immediately follows the launch of the Green Finance Framework as at 31 May 2022, which makes sustainability an intrinsic element of financing activities. Attachment

InterVest Investments

102 Investments

InterVest has made 102 investments. Their latest investment was in PineTree Therapeutics as part of their Series A on June 6, 2022.

CBI Logo

InterVest Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

6/7/2022

Series A

PineTree Therapeutics

$23.5M

Yes

2

5/26/2022

Series A

UMAG

$4.04M

Yes

1

5/10/2022

Series C

MyRealPlan

$8.01M

No

2

4/28/2022

Series B

Subscribe to see more

$99M

Subscribe to see more

10

3/31/2022

Series B

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/7/2022

5/26/2022

5/10/2022

4/28/2022

3/31/2022

Round

Series A

Series A

Series C

Series B

Series B

Company

PineTree Therapeutics

UMAG

MyRealPlan

Subscribe to see more

Subscribe to see more

Amount

$23.5M

$4.04M

$8.01M

$99M

$99M

New?

Yes

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

1

2

10

10

InterVest Portfolio Exits

9 Portfolio Exits

InterVest has 9 portfolio exits. Their latest portfolio exit was Lunit on July 21, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

7/21/2022

IPO

$99M

Public

2

7/19/2022

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

12/21/2020

IPO

Subscribe to see more

$99M

Subscribe to see more

10

8/4/2020

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

12/25/2019

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/21/2022

7/19/2022

12/21/2020

8/4/2020

12/25/2019

Exit

IPO

Acquired

IPO

Acquired

IPO

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

2

10

10

10

10

InterVest Fund History

2 Fund Histories

InterVest has 2 funds, including InterVest Star Southeast Asia Growth Fund I.

Closing Date

Fund

Fund Type

Status

Amount

Sources

12/5/2017

InterVest Star Southeast Asia Growth Fund I

Multi-Stage Venture Capital

Open

$60M

1

8/14/2013

Global Pharmaceutical Fund

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

12/5/2017

8/14/2013

Fund

InterVest Star Southeast Asia Growth Fund I

Global Pharmaceutical Fund

Fund Type

Multi-Stage Venture Capital

Subscribe to see more

Status

Open

Subscribe to see more

Amount

$60M

$99M

Sources

1

10

InterVest Team

2 Team Members

InterVest has 2 team members, including current Chief Executive Officer, President, Tae-Yong Lee.

Name

Work History

Title

Status

Tae-Yong Lee

Chief Executive Officer, President

Current

Junghee Lim

Managing Director

Current

Name

Tae-Yong Lee

Junghee Lim

Work History

Title

Chief Executive Officer, President

Managing Director

Status

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.